What is NDC 76045-210?

76045-210 is the product NDC for Dexamethasone Sodium Phosphate, Dexamethasone sodium phosphate 4 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 76045. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dexamethasone Sodium Phosphate?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dexamethasone Sodium Phosphate NDC 76045-210

NDC codes

FDA NDC Directory

Product NDC (as listed)76045-210Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76045-0210Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76045-210-10	7604502101076045021010	24 BLISTER PACK in 1 CARTON (76045-210-10) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-210-00) / 1 mL in 1 SYRINGE, GLASSMarketed from Nov 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 4 mg/mL
Dosage form: Injection, Solution
Route: Intra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue
Labeler: Fresenius Kabi USA, LLCNDC labeler code 76045
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203129
Marketing start: Nov 30, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 76045-210_9af24370-ee9f-4005-b1e9-96eef58fbde5SPL ID 9af24370-ee9f-4005-b1e9-96eef58fbde5SPL set ID ce25183b-cd67-4997-8de9-df59b750883bRxCUI 1812095UNII AI9376Y64P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N476045021010 followed by a unit qualifier and the quantity

Package 76045-0210-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 24, 2025.

Indications (excerpt from the label)

INDICATIONS A. Intravenous or intramuscular administration. When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; minera…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 76045-210

What is NDC 76045-210?: 76045-210 is the product NDC for Dexamethasone Sodium Phosphate, Dexamethasone sodium phosphate 4 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dexamethasone Sodium Phosphate.
What is the active ingredient?: Dexamethasone sodium phosphate.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 76045. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dexamethasone Sodium Phosphate?: 94 other product NDCs are listed under this name. See all Dexamethasone Sodium Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dexamethasone Sodium Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	REMEDYREPACK INC.	70518-4372	70518-4372-00
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals	72485-118	72485-0118-25
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Henry Schein, Inc.	0404-9795	00404-9795-30
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Henry Schein, Inc.	0404-9805	00404-9805-05
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Medical Purchasing Solutions, LLC.	71872-7347	71872-7347-01
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Sagent Pharmaceuticals	25021-052	25021-0052-0125021-0052-05
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Sagent Pharmaceuticals	25021-053	25021-0053-01
Dexamethasone sodium phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Micro Labs Limited	42571-432	42571-0432-4042571-0432-79
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, EmulsionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	76045-212	76045-0212-10
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Gland Pharma Limited	68083-607	68083-0607-25

All 95 Dexamethasone Sodium Phosphate NDCs

Other NDCs under ANDA 203129

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203129
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Fresenius Kabi USA, LLC	76045-106